Place · Level 3
全球卖得最好的护肝草药 · 试管里的机制是真的, 但口服几乎到不了肝 · 静脉那一版是鹅膏菌中毒的真解毒剂, 干的却是另一件事 · Cochrane 与 SyNCH 大试验阴性 · 安全, 但它替掉的东西才是代价
regulates · 1
In cell and animal work silybin partly restores depleted glutathione, but very low oral exposure — circulating mostly as conjugates — is what decides whether that step can happen in a person.
contrast · 8
Milk thistle is the commonest ingredient on the liver-pill shelf, yet the liver's own phase I/II clearance workshop already runs continuously, and pooled randomized trials show no effect on mortality or complications of liver disease.
No herb has been shown to clear hepatitis B virus; pooling randomized trials in alcoholic and hepatitis B/C liver disease, milk thistle showed no significant effect on mortality or complications.
In the steatohepatitis trial that read its endpoint from liver biopsy, 700 mg three times daily for 48 weeks failed the primary endpoint; the fibrosis-score improvement was a secondary finding.
Milk thistle is often treated as permission to keep drinking, yet in alcoholic liver disease it showed no significant effect on mortality or complications; what changes outcome is the load on the ethanol-dismantling pathway itself.
Both are sold as liver supplements, and both of their genuinely established clinical roles are intravenous and emergency — silibinin for Amanita poisoning, NAC for acetaminophen overdose — not at shelf doses.
The same bioavailability predicament: both act in a dish, while poor absorption plus rapid phase II conjugation after swallowing leaves free active compound far below experimental concentrations.
Two specimens of one pattern: early small trials uniformly positive, then large randomized trials nulled it — Cochrane pooling and SyNCH for milk thistle, STEP and CAMUS for saw palmetto.
The two ends of herbal safety: milk thistle is rated likelihood category E (unlikely) for liver injury, while Polygonum multiflorum carries documented injury in the same database — 'natural' means neither safe nor dangerous by itself.